Literature DB >> 870684

Effect of warfarin on the kinetics of the vitamin K-dependent clotting factors in rats.

H Vainieri, L B Wingard.   

Abstract

The objectives of this study were to compare the time course of activities and rates of synthesis of activities for the separate clotting factors II, VII, IX, and X and to relate the rate of synthesis of activity of each factor to the plasma concentration of warfarin in individual rats after acute and chronic dosing with warfarin. Sequences of blood samples were obtained from each rat for 50 to 70 hours after an acute dose of warfarin or for 120 hours after a chronic loading dose plus 12-hour maintenance doses of warfarin and assayed for factor activities and warfarin concentration. The half-lives for degradation of factor activities ranged from 2.6 to 9.0 hours for the four factors. During periods of changing warfarin concentration (acute dosing) factor VII and X activities and rates of synthesis of activity showed large rapid changes, while factors II and IX responded more slowly. As the warfarin concentration diminished, the factor X rate of synthesis of activity appeared to exceed predrug values in all rats. During chronic dosing with warfarin the factor II activity and rate of synthesis of activity was depressed the most. The percent depression of the rate of synthesis of activity for each factor was related linearly to the logarithm of the plasma concentration of warfarin for the range 0 to 80% depression with acute dosing. However, this relationship was not suitable to explain the apparent overshoot in factor X rate of synthesis of activity.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 870684

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  4 in total

1.  A Joint Model for Vitamin K-Dependent Clotting Factors and Anticoagulation Proteins.

Authors:  Qing Xi Ooi; Daniel F B Wright; R Campbell Tait; Geoffrey K Isbister; Stephen B Duffull
Journal:  Clin Pharmacokinet       Date:  2017-12       Impact factor: 6.447

2.  Preliminary outcomes of preemptive warfarin pharmacogenetic testing at a large rural healthcare center.

Authors:  Emili Leary; Murray Brilliant; Peggy Peissig; Sara Griesbach
Journal:  Am J Health Syst Pharm       Date:  2019-02-21       Impact factor: 2.637

3.  The anticoagulant, antithrombotic and haemorrhagic effect of long-term warfarin on experimental venous and arterial thrombosis in the rat.

Authors:  M MacIomhair; S M Lavelle
Journal:  Ir J Med Sci       Date:  1996 Jul-Sep       Impact factor: 1.568

4.  Rapid reversal of anticoagulation reduces hemorrhage volume in a mouse model of warfarin-associated intracerebral hemorrhage.

Authors:  Christian Foerch; Ken Arai; Elizabeth Merrill Van Cott; Klaus van Leyen; Eng H Lo
Journal:  J Cereb Blood Flow Metab       Date:  2009-03-25       Impact factor: 6.200

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.